Global Infectious Disease Market 2026-2030

Global Infectious Disease Market 2026-2030

The global infectious disease market is forecasted to grow by USD 171324.2 mn during 2025-2030, accelerating at a CAGR of 14.1% during the forecast period. The report on the global infectious disease market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating global burden of pathogenic illnesses, proliferation of antimicrobial resistance, technological advancements in molecular diagnostics and vaccinology.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global infectious disease market is segmented as below:

By Product

• Drugs
• Vaccines

By End-User

• Hospital
• Multispecialty clinic
• Others

By Type

• Bacterial infections
• Viral infections
• Fungal infections
• Parasitic infections

Geography

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the acceleration of decentralized poc testing platforms as one of the prime reasons driving the global infectious disease market growth during the next few years. Also, integration of ai in pathogen surveillance and drug discovery and emergence of universal and multi-target vaccine technologies will lead to sizable demand in the market.

The report on the global infectious disease market covers the following areas:

• Global infectious disease market sizing
• Global infectious disease market forecast
• Global infectious disease market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global infectious disease market vendors that include Abbott Laboratories, AstraZeneca Plc, Becton Dickinson and Co., Bio Rad Laboratories Inc., Cepheid Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Hologic Inc., Illumina Inc., Johnson and Johnson Services, Merck and Co. Inc., Novartis AG, PerkinElmer US LLC, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Siemens Healthineers AG, Thermo Fisher Scientific Inc.. Also, the global infectious disease market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth. Show more